Recent developments in pig kidney transplants have shown promise as a potential treatment for end-stage kidney disease. A U.S. man has survived six months after receiving a pig kidney transplant, highlighting the potential for xenotransplantation to become a clinical reality. The FDA has approved human trials for gene-edited pig kidneys, with several New Hampshire residents participating in successful transplant procedures. With approximately 37 million adults suffering from chronic kidney disease, these advancements provide hope for many patients as trials are set to expand in various hospitals, including one in Boston.